Skip to main content
Log in

Elektive nicht kardiochirurgische Operationen bei Patienten mit kardialer Grunderkrankung

Präoperative Risikoeinschätzung und perioperatives Vorgehen

Elective non-cardiac surgery in patients with underlying cardiac disease

Preoperative risk assessment and perioperative approach

  • Leitthema
  • Published:
Gefässchirurgie Aims and scope Submit manuscript

Zusammenfassung

Das perioperative Risiko einer unerwünschten kardialen Komplikation hängt im Wesentlichen von der präoperativen Konstitution des Patienten, dessen Begleiterkrankungen und der Größe bzw. Länge der geplanten Operation ab.

Um das perioperative kardiale Risiko besser einschätzen zu können und um die perioperative Behandlungsmöglichkeiten und das postoperative Ergebnis zu verbessern, hat die europäische Gesellschaft für Kardiologie in Zusammenarbeit mit der europäischen Gesellschaft für Anästhesiologie im Jahr 2009 neue Leitlinien verfasst. Diese Leitlinien setzen zwei Schwerpunkte: die präoperative Risikoeinschätzung, abgeleitet aus den Begleiterkrankungen des Patienten und aus der Schwere bzw. Länge des geplanten chirurgischen Eingriffes, sowie das perioperative Management in Abhängigkeit von der zuvor festgelegten Risikoeinschätzung.

In Anlehnung an diese Leitlinien gibt dieser Artikel einen kurzen Überblick zu dem Thema, wobei sich insbesondere auf die vorbestehenden kardialen Begleiterkrankungen und das perioperative kardiale Management konzentriert wird.

Abstract

The perioperative risk of a cardiac complication is primarily determined by the patient’s preoperative constitution, any existing comorbidities as well as the extent and the duration of the intended surgery. Consequently, the European Society of Cardiology (ESC) endorsed by the European Society of Anaesthesiology (ESA) published guidelines in 2009 aiming at improving perioperative cardiac risk assessment and perioperative treatment as well as the postoperative outcome. In line with these objectives the guidelines mainly focus on two areas: the preoperative risk assessment based on the patients’ comorbidities and the anticipated severity of the intended surgery itself and secondly on the perioperative management derived from the outcome of the previous risk assessment. On the basis of these guidelines this article gives a brief overview on the subject focusing on existing cardiac comorbidities and perioperative cardiac management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Abbreviations

MET:

Metabolic equivalent

TIA:

Transistorisch Ischämische Attacke

AICD:

Automatic implantable cardioverter defibrillator

LV- Funktion:

Linksventrikuläre Funktion

NSTEMI:

Nicht ST-Strecken Hebungsinfarkt

BMS:

Bare metal Stent

DES:

Drug-eluting Stent

PCI:

Perkutane koronar Intervention

PTCA:

Perkutane transluminale Ballonangioplastie

Literatur

  1. Almanaseer Y, Mukherjee D, Kline-Rogers EM et al (2005) Implementation of the ACC/AHA guidelines for preoperative cardiac risk assessment in a general medicine preoperative clinic: improving efficiency and preserving outcomes. Cardiology 103:24–29

    Article  PubMed  Google Scholar 

  2. Biondi-Zoccai GG, Lotrionte M, Agostoni P et al (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27:2667–2674

    Article  PubMed  Google Scholar 

  3. Boersma E, Kertai MD, Schouten O et al (2005) Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 118:1134–1141

    Article  PubMed  Google Scholar 

  4. Brady AR, Gibbs JS, Greenhalgh RM et al (2005) Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41:602–609

    Article  PubMed  CAS  Google Scholar 

  5. Burger W, Chemnitius JM, Kneissl GD et al (2005) Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Intern Med 257:399–414

    Article  PubMed  CAS  Google Scholar 

  6. Devereaux PJ, Yang H, Yusuf S et al (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371:1839–1847

    Article  PubMed  CAS  Google Scholar 

  7. Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442

    Article  PubMed  CAS  Google Scholar 

  8. Dunkelgrun M, Boersma E, Schouten O et al (2009) Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 249:921–926

    Article  PubMed  Google Scholar 

  9. Elhendy A, Valkema R, Van Domburg RT et al (1998) Safety of dobutamine-atropine stress myocardial perfusion scintigraphy. J Nucl Med 39:1662–1666

    PubMed  CAS  Google Scholar 

  10. Ferguson TB Jr, Hammill BG, Peterson ED et al (2002) A decade of change – risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990–1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg 73:480–489; discussion 489–490

    Article  PubMed  Google Scholar 

  11. Fox K, Garcia MA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European Society of Cardiology. Eur Heart J 27:1341–1381

    Article  PubMed  Google Scholar 

  12. Graham I, Atar D, Borch-Johnsen K et al (2007) European guidelines on cardiovascular disease prevention in clinical practice: executive summary: fourth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 28:2375–2414

    Article  PubMed  Google Scholar 

  13. Howard-Alpe GM, De Bono J, Hudsmith L et al (2007) Coronary artery stents and non-cardiac surgery. Br J Anaesth 98:560–574

    Article  PubMed  CAS  Google Scholar 

  14. Huber KC, Evans MA, Bresnahan JF et al (1992) Outcome of noncardiac operations in patients with severe coronary artery disease successfully treated preoperatively with coronary angioplasty. Mayo Clinic proceedings. Mayo Clinic 67:15–21

    Article  CAS  Google Scholar 

  15. Juul AB, Wetterslev J, Gluud C et al (2006) Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ (Clinical research ed.) 332:1482

  16. Kaluza GL, Joseph J, Lee JR et al (2000) Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35:1288–1294

    Article  PubMed  CAS  Google Scholar 

  17. Kelm M, Osterhues H, Hennerici MG et al (2010) Kommentar zu den ESC Guidelines for Pre-Operative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-Cardiac Surgery. Der Kardiologe 5:375–382

    Article  Google Scholar 

  18. Kertai MD, Boersma E, Bax JJ et al (2003) A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart (British Cardiac Society) 89:1327–1334

    Google Scholar 

  19. Lee TH, Marcantonio ER, Mangione CM et al (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100:1043–1049

    Article  PubMed  CAS  Google Scholar 

  20. Mangano DT (2004) Perioperative medicine: NHLBI working group deliberations and recommendations. J Cardiothorac Vasc Anesth 18:1–6

    Article  PubMed  Google Scholar 

  21. Mangano DT, Goldman L (1995) Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med 333:1750–1756

    Article  PubMed  CAS  Google Scholar 

  22. Mangano DT, Layug EL, Wallace A et al (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335:1713–1720

    Article  PubMed  CAS  Google Scholar 

  23. Morris CK, Ueshima K, Kawaguchi T et al (1991) The prognostic value of exercise capacity: a review of the literature. Am Heart J 122:1423–1431

    Article  PubMed  CAS  Google Scholar 

  24. Naughton C, Feneck RO (2007) The impact of age on 6-month survival in patients with cardiovascular risk factors undergoing elective non-cardiac surgery. Int J Clin Pract 61:768–776

    Article  PubMed  CAS  Google Scholar 

  25. Nuttall GA, Brown MJ, Stombaugh JW et al (2008) Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 109:588–595

    Article  PubMed  Google Scholar 

  26. Oosterga M, Voors AA, Pinto YM et al (2001) Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. Am J Cardiol 87:542–546

    Article  PubMed  CAS  Google Scholar 

  27. Poldermans D, Bax JJ, Boersma E et al (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 30:2769–2812

    Article  PubMed  Google Scholar 

  28. Poldermans D, Bax JJ, Kertai MD et al (2003) Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107:1848–1851

    Article  PubMed  CAS  Google Scholar 

  29. Poldermans D, Bax JJ, Schouten O et al (2006) Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol 48:964–969

    Article  PubMed  CAS  Google Scholar 

  30. Poldermans D, Boersma E, Bax JJ et al (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341:1789–1794

    Article  PubMed  CAS  Google Scholar 

  31. Rosenson RS, Tangney CC (1998) Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 279:1643–1650

    Article  PubMed  CAS  Google Scholar 

  32. Schiefermueller J, Myerson S, Handa AI (2012) Preoperative assessment and perioperative management of cardiovascular risk. Angiology. Epub ahead of print

  33. Sicari R, Nihoyannopoulos P, Evangelista A et al (2009) Stress echocardiography expert consensus statement-executive summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 30:278–289

    Article  PubMed  Google Scholar 

  34. Sun YP, Zhu BQ, Browne AE et al (2001) Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function. J Cardiovasc Pharmacol Ther 6:175–181

    Article  PubMed  CAS  Google Scholar 

  35. Wiklund RA, Stein HD, Rosenbaum SH (2001) Activities of daily living and cardiovascular complications following elective, noncardiac surgery. YJBM 74:75–87

    PubMed  CAS  Google Scholar 

  36. Yang H, Raymer K, Butler R et al (2006) The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152:983–990

    Article  PubMed  CAS  Google Scholar 

  37. Zaugg M, Bestmann L, Wacker J et al (2007) Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 107:33–44

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Die korrespondierende Autorin gibt für sich und ihre Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Markworth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Markworth, F., Debus, E. & Blankenberg, S. Elektive nicht kardiochirurgische Operationen bei Patienten mit kardialer Grunderkrankung. Gefässchirurgie 18, 21–27 (2013). https://doi.org/10.1007/s00772-012-1108-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00772-012-1108-2

Schlüsselwörter

Keywords

Navigation